Change search
ReferencesLink to record
Permanent link

Direct link
Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel
Show others and affiliations
2011 (English)In: PLoS ONE, ISSN 1932-6203, Vol. 6, no 4, 1-10 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2011. Vol. 6, no 4, 1-10 p.
URN: urn:nbn:no:ntnu:diva-17195DOI: 10.1371/journal.pone.0019249OAI: diva2:546109
Available from: 2012-08-22 Created: 2012-08-22 Last updated: 2012-08-22Bibliographically approved

Open Access in DiVA

fulltekst(579 kB)45 downloads
File information
File name FULLTEXT01.pdfFile size 579 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text
By organisation
Department of Cancer Research and Molecular Medicine
In the same journal

Search outside of DiVA

GoogleGoogle Scholar
Total: 45 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 48 hits
ReferencesLink to record
Permanent link

Direct link